Results 291 to 295 of about 504,547 (295)

Journey of Von Hippel-Lindau (VHL) E3 Ligase in PROTACs Design: From VHL Ligands to VHL-Based Degraders

European Journal of Medicinal Chemistry
Mohammad Abid, Haider Thaer Abdulhameed Almuqdadi   +1 more
exaly  

Identification of an allosteric site on the E3 ligase adapter cereblon.

Nature
Vanessa N. Dippon, Zeba Rizvi, A. Choudhry, Chun-Wa Chung, Ibrahim F. Alkuraya, Wen-Qing Xu, Xavier B. Tao, A. Jurewicz, Jessica L. Schneck, Wenqian Chen, Nicole M Curnutt, F. Kabir, Kwok-Ho Chan, M. Queisser, C. Musetti, H. Dai, G. Lander, Andrew B. Benowitz, Christina M. Woo   +18 more
semanticscholar   +1 more source

DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE

2022
LEI BAILIN, LIU HUAQING, HAN SONGZHE, WANG ZHIWEI   +3 more
openaire   +1 more source

CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS

2023
YANG XIAOBAO, SUN RENHONG, ZHAO BAOYIN
openaire   +1 more source

Dual Target E3 Ligase Ligands: A New Way to Overcome Drug Resistance

Hans Journal of Medicinal Chemistry
openaire   +1 more source